NextPlat Corp (NASDAQ:NXPL) Sees Significant Decline in Short Interest

NextPlat Corp (NASDAQ:NXPL) was the recipient of a significant decrease in short interest in the month of February. As of February 28th, there was short interest totalling 84,900 shares, a decrease of 26.5% from the February 13th total of 115,500 shares. Currently, 0.6% of the company’s stock are sold short. Based on an average daily volume of 377,200 shares, the short-interest ratio is presently 0.2 days.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in NextPlat stock. Renaissance Technologies LLC bought a new position in NextPlat Corp (NASDAQ:NXPL) during the fourth quarter, according to its most recent filing with the SEC. The firm bought 28,000 shares of the company’s stock, valued at approximately $30,000. Renaissance Technologies LLC owned approximately 0.11% of NextPlat as of its most recent SEC filing. Institutional investors and hedge funds own 1.30% of the company’s stock.

NextPlat Stock Down 5.0 %

Shares of NASDAQ NXPL traded down $0.05 during trading on Tuesday, hitting $0.95. 27,611 shares of the company traded hands, compared to its average volume of 348,044. The business’s fifty day moving average is $1.05 and its 200 day moving average is $1.11. NextPlat has a fifty-two week low of $0.71 and a fifty-two week high of $2.68. The firm has a market capitalization of $24.66 million, a price-to-earnings ratio of -1.40 and a beta of 0.79. The company has a debt-to-equity ratio of 0.04, a quick ratio of 3.04 and a current ratio of 3.70.

About NextPlat

NextPlat Corp operates as a healthcare and e-commerce company in Europe, North America, South America, the Asia and Pacific, and Africa. The company operates full-service retail specialty services pharmacies that provides prescription pharmaceuticals prescription pharmaceuticals, third-party administration, risk and data management services, compounded medications, tele-pharmacy services, anti-retroviral medications, medication therapy management, contracted pharmacy services, and health practice risk management to healthcare organizations and providers, as well as supplies prescription medications to long-term care facilities.